# EDGAR Filing Document

**Accession Number:** 0001590695
**File Stem:** 0001753926-23-000152
**Filing Date:** 2023-2
**Character Count:** 4749
**Document Hash:** 3d32426cb3e02352f7d13d4b5b484bc5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001753926-23-000152.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001753926-23-000152

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230206

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TWINLAB CONSOLIDATED HOLDINGS, INC.
- **CENTRAL INDEX KEY:** 0001590695
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **IRS NUMBER:** 463951742
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-55181
- **FILM NUMBER:** 23627866

**BUSINESS ADDRESS:**
- **STREET 1:** 4800 T-REX AVENUE
- **STREET 2:** SUITE 305
- **CITY:** BOCA RATON
- **STATE:** FL
- **ZIP:** 33431
- **BUSINESS PHONE:** 561-443-5001

**MAIL ADDRESS:**
- **STREET 1:** 4800 T-REX AVENUE
- **STREET 2:** SUITE 305
- **CITY:** BOCA RATON
- **STATE:** FL
- **ZIP:** 33431

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MIRROR ME, INC.
- **DATE OF NAME CHANGE:** 20131031

tlcc-20230206.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K CURRENT REPORT**

**Pursuant to Section 13OR15(d) of The Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported):**<u>February 6, 2023</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>**

---

| |
|:---|
| **TWINLAB CONSOLIDATED HOLDINGS, INC.** |
| (Exact name of registrant as specified in its charter) |

---

---

| | | |
|:---|:---|:---|
| **Nevada** | **000-55181** | **46-3951742** |
| (State orotherjurisdiction ofincorporation) | (CommissionFileNumber) | (IRSEmployer IdentificationNo.) |

---

---

| | |
|:---|:---|
| **4800 T-Rex Avenue, Suite 225,Boca Raton,Florida** | **33431** |
| (Address of principalexecutiveoffices) | (Zip Code) |

---

---

| | |
|:---|:---|
| Registrant's telephone number, includingareacode | **(561)443-5301** |
| (Former name or former address, if changed since last report) | (Former name or former address, if changed since last report) |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<u>see</u> General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class  | Trading Symbol(s)  | Name of each exchange on which registered  |

---

IndicatebycheckmarkwhethertheregistrantisanemerginggrowthcompanyasdefinedinRule405oftheSecuritiesActof1933(§230.405ofthischapter)orRule12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter)

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Section 5 – Corporate Governance and Management**

**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

***Resignation of Director***

On February 6, 2023, via letter, Mr. Seth D. Ellis informed the Board of Directors (the "Board") of Twinlab Consolidated Holdings, Inc. ("the Company") that he was resigning from the Board and the Board's Audit Committee and Compensation Committee, effective immediately. His resignation is not a result of any disagreement with the Company.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **TWINLAB CONSOLIDATED HOLDINGS, INC.** | **TWINLAB CONSOLIDATED HOLDINGS, INC.** |
| Date: February 14, 2023 | By: | /s/ Kyle Casey |
|  |  | Kyle Casey |
|  |  | Interim Chief Executive Officer and Chief Financial Officer |

---